Pacira BioSciences, Inc. (NASDAQ:PCRX) is held by 253 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 6,735,343 | -328,937 | -4.66% | $152,218,750.00 |
| Doma Perpetual Capital Management LLC | 31 Mar, 2026 | 2,777,794 | 0 | 0.00% | $62,778,144.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 2,501,286 | 2,501,286 | 0.00% | $56,529,064.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 2,060,597 | 110,584 | 5.67% | $46,572,366.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 1,982,724 | -57,203 | -2.80% | $44,809,563.00 |
| State Street Corp | 31 Mar, 2026 | 1,919,610 | 36,243 | 1.92% | $43,383,186.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,825,501 | -58,500 | -3.11% | $41,256,323.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,784,049 | 1,784,049 | 0.00% | $40,319,507.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,569,916 | -1,030,858 | -39.64% | $35,480,101.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,392,548 | 199,954 | 16.77% | $31,471,623.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,143,820 | -25,771 | -2.20% | $25,855,369.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Mar, 2026 | 837,563 | -498,484 | -37.31% | $18,928,924.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 797,281 | -22,487 | -2.74% | $18,018,550.00 |
| Impax Asset Management Group plc | 31 Mar, 2026 | 750,027 | 0 | 0.00% | $16,950,610.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 732,042 | 55,690 | 8.23% | $16,544,149.00 |
| GAGNON SECURITIES LLC | 31 Mar, 2026 | 617,510 | 116,299 | 23.20% | $13,955,726.00 |
| UBS Group AG | 31 Mar, 2026 | 562,040 | 3,389 | 0.61% | $12,702,104.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 526,851 | 74,999 | 16.60% | $11,906,833.00 |
| Northern Trust Corp | 31 Mar, 2026 | 519,412 | -9,071 | -1.72% | $11,738,711.00 |
| LSV ASSET MANAGEMENT | 31 Mar, 2026 | 517,100 | 197,300 | 61.69% | $11,686.00 |